Heterologous Phosphorylation-induced Formation of a Stability Lock Permits Regulation of Inactive Receptors by β-arrestins
Overview
Authors
Affiliations
β-Arrestins are key regulators and signal transducers of G protein-coupled receptors (GPCRs). The interaction between receptors and β-arrestins is generally believed to require both receptor activity and phosphorylation by GPCR kinases. In this study, we investigated whether β-arrestins are able to bind second messenger kinase-phosphorylated, but inactive receptors as well. Because heterologous phosphorylation is a common phenomenon among GPCRs, this mode of β-arrestin activation may represent a novel mechanism of signal transduction and receptor cross-talk. Here we demonstrate that activation of protein kinase C (PKC) by phorbol myristate acetate, G-coupled GPCR, or epidermal growth factor receptor stimulation promotes β-arrestin2 recruitment to unliganded AT angiotensin receptor (ATR). We found that this interaction depends on the stability lock, a structure responsible for the sustained binding between GPCRs and β-arrestins, formed by phosphorylated serine-threonine clusters in the receptor's C terminus and two conserved phosphate-binding lysines in the β-arrestin2 N-domain. Using improved FlAsH-based serine-threonine clusters β-arrestin2 conformational biosensors, we also show that the stability lock not only stabilizes the receptor-β-arrestin interaction, but also governs the structural rearrangements within β-arrestins. Furthermore, we found that β-arrestin2 binds to PKC-phosphorylated ATR in a distinct active conformation, which triggers MAPK recruitment and receptor internalization. Our results provide new insights into the activation of β-arrestins and reveal their novel role in receptor cross-talk.
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors.
Toth A, Turu G, Hunyady L Nat Rev Nephrol. 2024; 20(11):722-741.
PMID: 39039165 DOI: 10.1038/s41581-024-00869-3.
Poonam , Chaudhary S Mol Biol Rep. 2023; 51(1):46.
PMID: 38158508 DOI: 10.1007/s11033-023-08995-0.
Shpakov A Int J Mol Sci. 2023; 24(7).
PMID: 37047169 PMC: 10094638. DOI: 10.3390/ijms24076187.
Szenasi T, Turu G, Hunyady L Front Endocrinol (Lausanne). 2023; 14:957981.
PMID: 36843600 PMC: 9947276. DOI: 10.3389/fendo.2023.957981.
Haider R, Matthees E, Drube J, Reichel M, Zabel U, Inoue A Nat Commun. 2022; 13(1):5638.
PMID: 36163356 PMC: 9512828. DOI: 10.1038/s41467-022-33307-8.